PO-1089: IORT for breast cancer treated with Axxent Xoft. Our experience: toxicity analysis. (April 2018) - Molina Osorio, J.G.; Ibáñez Carreras, R.; Oliver Guillén, J.R.; Lanzuela Valero, M.; Miranda Burgos, A.; Alled, L.; García Gímeno, B.; Matute Najarro, M.; Casamayor Franco, C.; García Mur, C.; Cruz Ciria, S.; Hernando Almudi, E.; et al.